Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 6Kidney Neoplasms 4Neoplasm Metastasis 2Glioblastoma 1Clear-cell metastatic renal cell carcinoma 1

Interventions

Nivolumab 4Ipilimumab 4Specimen Handling 3Magnetic Resonance Spectroscopy 3CTLA-4 Antigen 3Sunitinib 2pembrolizumab 1pazopanib 1fludarabine 1cabozantinib 1belzutifan 1atezolizumab 1aldesleukin 1Immunoglobulin G 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Clear-cell metastatic renal cell carcinoma × belzutifan × Clear all
NCT07179770 2025-09-23

Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)

NYU Langone Health

Phase 1 Recruiting
12 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡